• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access

Opinion
Video

Experts discuss which patient populations stand to benefit the most from recently approved bispecific therapies, identifying gaps or opportunities for further patient benefit, as well as the data gaps that exist in understanding the optimal use of bispecific antibodies across various cancer types.

Video content above is prompted by the following:

  • What patient populations stand to benefit the most from recently approved bispecific therapies?
  • Where are gaps or opportunities for patient populations to further benefit from bispecifics?
  • What data gaps exist in understanding the optimal use of bispecific antibodies across various cancer types?
Related Videos
1 expert is featured in this series.
3 experts are featured in this series.
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.